5 months Coming to a CVS Near You: A Store Brand Monoclonal Antibody The Wall Street Journal
CVS is getting into the business of making copycat biologic drugs, known as biosimilars, to profit directly from blockbusters going generic.
Business · CVS Health Corp (CVS)